Stock screenerAll disclosures →
EDGAR →
JUNS
Conviction 67HealthcareScan · Tue, Sep 8, 2026JUNS$3.11-5.18%
ResistanceSupportVol 14Vol MA14 3.88M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price3.11
Change-5.18%
Gap-2.44%
Rel volume0.02×
Avg volume2.74M
Avg $ vol16.84M
SMA 204.59
SMA 502.13
SMA 2000.9832
Price vs 50+45.79%
Price vs 200+216.33%
MA stackbullish
50/200 cross—
Supertrenddown · 5.28
RSI (14)46
MACD hist-0.39
MACD crossbear · 7d
Stoch %K / %D3 / 4
ADX (14)49
+DI / −DI45 / 22
RSI divergenceBearish
MACD divergenceBearish
ATR %+22.49%
ADR %16.32%
52w high6.20
52w low0.0751
From 52w high-49.84%
Above 52w low+4041.15%
New 52w highNo
SqueezeOff
Bollinger width81.58%
%B0.10
Donchian pos2.76%
Donchian high11.20
Donchian low2.88
AVWAP (52w high)7.53
vs AVWAP high-58.72%
AVWAP (52w low)6.54
vs AVWAP low-52.44%
OBV trendUp
Chaikin MF (20)-0.72
Today vs 20d0.02×
Avg vol (14d)3.88M
Avg vol (20d)2.74M
Avg $ vol (20d)16.84M
Market cap2.39M
RS 3m (vs SPY)+1250.39%
RS 6m (vs SPY)+733.00%
RS line new highNo
Trend template5/8
Technical rank76.1
1 week-12.15%
1 month-39.02%
3 months+1246.32%
6 months+633.14%
1 year+152.85%
YTD+207.92%
P/E-0.28
P/B-6.54
P/S109.88
P/FCF—
EPS-0.2500
Div yield—
ROE—
ROA-232.48%
Debt/Eq—
Current0.66
EV/EBITDA—
Gross margin80.59%
Net margin—
Rev growth—
EPS growth-254.35%
Price target—
Target upside—
Analyst rating—
Institutional1.64%
Ent. value2.39M
Revenue24.25K
Net income-2.27M
Gross profit21.06K
Free cash flow—
IndustryPharmaceutical Preparations
ExchangeNasdaq
Shares out36.28M
Employees5
ListedTue, Dec 3, 2024
Free float7.35M
Float %21.4%
Short interest29.68K
Days to cover0.3d
Short volume42.2%
Squeeze score4 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction67 / 100
Pattern quality—
Tech rank76.1 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance8.65
Support0.0771
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in JUNS
No recent disclosed trades by Congress in JUNS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in JUNS · 5 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Cutler Andrew Jon Director · Stock Option (right to buy) · 2026-07-31 | Grant | 472.22K | — | 2026-07-31 | 2026-08-05 |
Hayward Marshall A. Chief Scientific Officer · Common Stock · 2026-03-02 | Exercise | 225K | — | 2026-03-02 | 2026-07-13 |
Hayward Marshall A. Chief Scientific Officer · Stock Option (right to buy) · 2026-03-02 | Exercise | 225K | — | 2026-03-02 | 2026-07-13 |
Hayward Marshall A. Chief Scientific Officer · Restricted Stock Units · 2025-06-02 | Exercise | 389.79K | — | 2025-06-02 | 2026-07-13 |
Hayward Marshall A. Chief Scientific Officer · Restricted Stock Award · 2025-06-02 | Exercise | 399.4K | — | 2025-06-02 | 2026-07-13 |
Hemmerly Nicholas H. Director · Common Stock · 2025-06-02 | Exercise | 95.55K | — | 2025-06-02 | 2026-07-13 |
Hemmerly Nicholas H. Director · Restricted Stock Units · 2025-06-02 | Exercise | 95.55K | — | 2025-06-02 | 2026-07-13 |
Weis Holger Director · Common Stock · 2025-06-02 | Exercise | 85.8K | — | 2025-06-02 | 2026-07-13 |
Weis Holger Director · Restricted Stock Units · 2025-06-02 | Exercise | 85.8K | — | 2025-06-02 | 2026-07-13 |
Rosen Alexander Gustaf Erik Chief Administrative Officer · Common Stock · 2025-06-02 | Exercise | 164.55K | — | 2025-06-02 | 2026-07-13 |
SEC filings
EDGAR filings in JUNS · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.